TTK and glioblastoma: In addition, TTK has been discovered to function as an oncogene in various cancers [12–14, 18–21], and TTK inhibition has already been studied as a targeted therapy for breast cancer, glioblastoma, liver cancer and other tumors [15, 16, 22, 33].